Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand’s disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score-Reference-Cited by-同舟云学术

Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand’s disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score

Published:2010-01 Issue:1 Volume:16 Page:101-110
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

FEDERICI A. B.,BARILLARI G.,ZANON E.,MAZZUCCONI M. G.,MUSSO R.,TARGHETTA R.,MANNUCCI P. M.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2009.02088.x/fullpdf

Reference32 articles.

1. Management of inherited von Willebrand disease in 2007;Federici;Ann Med,2007

2. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor;Sadler;J Thromb Haemost,2006

3. Guidelines for the diagnosis and management of von Willebrand disease in Italy;Federici;Haemophilia,2002

4. Treatment of von Willebrand’s Disease;Mannucci;N Engl J Med,2004

5. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007);Federici;Haemophilia,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy;Clinical and Applied Thrombosis/Hemostasis;2024-07-21

2. Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology;Annals of Critical Care;2024-01-27

3. Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort;Clinical Drug Investigation;2023-11-30

4. pH-dependent conformation of multimeric von Willebrand factor;Blood Advances;2023-06-02

5. Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report;Hematology;2023-03-09